References
- Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999–2017 on CDC WONDER Online Database. Data are from the Multiple Cause of Death Files, 1999–2017, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed 2018.
- National AE, Prevention P. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94.
- Carryer HM, Koelsche GA, Prickman LE, Maytum CK, Lake CF, Williams HL. The effect of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. J Allergy Clin Immunol 1950;21:282–287.
- 2019 GINA Report, Global Strategy for Asthma Management and Prevention 2019.
- Littenberg B, Gluck EH. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med 1986;314(3):150–152. doi:https://doi.org/10.1056/NEJM198601163140304.
- Scarfone RJ, Friedlaender E. Corticosteroids in acute asthma: past, present, and future. Pediatr Emerg Care 2003;19:355–361.
- Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92:513–518.
- Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013;9(1):30. doi:https://doi.org/10.1186/1710-1492-9-30.
- Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996;154(2 Pt 2):S21–S27. doi:https://doi.org/10.1164/ajrccm/154.2_Pt_2.S21.
- Hendeles L. Selecting a systemic corticosteroid for acute asthma in young children. J Pediatr 2003;142(2 Suppl):S40–S44. doi:https://doi.org/10.1067/mpd.2003.25.
- Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog 2013;60(1):25–32. doi:https://doi.org/10.2344/0003-3006-60.1.25.
- Kim MK, Yen K, Redman RL, Nelson TJ, Brandos J, Hennes HM. Vomiting of liquid corticosteroids in children with asthma. Pediatr Emerg Care 2006;22(6):397–401. doi:https://doi.org/10.1097/01.pec.0000221338.44798.6a.
- Aggarwal P, Bhoi S. Comparing the efficacy and safety of two regimens of sequential systemic corticosteroids in the treatment of acute exacerbation of bronchial asthma. J Emerg Trauma Shock 2010;3(3):231. doi:https://doi.org/10.4103/0974-2700.66522.
- Dembla G, Mundle R, Salkar H, Doifoide D. Oral versus intravenous steroids in acute exacerbation of asthma-randomized controlled study. J Assoc Physicians India 2011;59:621–623.
- Rowe B, Edmonds M, Spooner C, Diner B, Camargo C. Corticosteroid therapy for acute asthma. Respir Med 2004;98(4):275–284. doi:https://doi.org/10.1016/j.rmed.2003.11.016.
- Engel T, Heinig J. Glucocorticosteroid therapy in acute severe asthma–a critical review. Eur Respir J 1991;4:881–889.
- Pierson WE, Bierman CW, Kelley V. A double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics 1974;54(3):282–288.
- Keeney GE, Gray MP, Morrison AK, Levas MN, Kessler EA, Hill GD, Gorelick MH, Jackson JL. Dexamethasone for acute asthma exacerbations in children: a meta-analysis. Pediatrics 2014;133(3):493–499. doi:https://doi.org/10.1542/peds.2013-2273.
- Nievas IF, Anand KJ. Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther 2013;18(2):88–104. doi:https://doi.org/10.5863/1551-6776-18.2.88.
- Team RC. R: A language and environment for statistical computing: R Foundation for Statistical Computing; 2018.
- Team R. RStudio: integrated development for R. RStudio, Inc., Boston, MA. http://www.rstudio.com. 2015;42:14.
- Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, NHLBI AsthmaNet, et al. Step-up therapy in black children and adults with poorly controlled asthma. N Engl J Med 2019;381(13):1227–1239. doi:https://doi.org/10.1056/NEJMoa1905560.
- Nyenhuis SM, Krishnan JA, Berry A, Calhoun WJ, Chinchilli VM, Engle L, Grossman N, Holguin F, Israel E, Kittles RA, et al. Race is associated with differences in airway inflammation in patients with asthma. J Allergy Clin Immunol 2017;140(1):257–265.e211. doi:https://doi.org/10.1016/j.jaci.2016.10.024.
- Federico MJ, Covar RA, Brown EE, Leung DYM, Spahn JD. Racial differences in T-lymphocyte response to glucocorticoids. Chest 2005;127(2):571–578. doi:https://doi.org/10.1378/chest.127.2.571.
- Boeschoten S, de Hoog M, Kneyber M, Merkus P, Boehmer A, Buysse C. Current practices in children with severe acute asthma across European PICUs: an ESPNIC survey. Eur J Pediatr 2020;179(3):455–457. doi:https://doi.org/10.1007/s00431-019-03502-9.
- Giuliano JS, Faustino EVS, Li S, Pinto MG, Canarie MF, Carroll CL, Northeast Pediatric Critical Care Research Consortium (NEPCCRC). Corticosteroid therapy in critically ill pediatric asthmatic patients. Pediatr Crit Care Med 2013;14(5):467–470. doi:https://doi.org/10.1097/PCC.0b013e31828a7451.
- Manser R, Reid D, Abramson MJ. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database Syst Rev 2001;(1):CD001740.
- Raimondi AC, Figueroa-Casas JC, Roncoroni AJ. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest 1986;89(6):832–835. doi:https://doi.org/10.1378/chest.89.6.832.
- Lexi-Drugs. Lexicomp: Wolters Kluwer Health, Inc.; 2019.
- Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period. Pediatrics 2010;126(4):904–911. doi:https://doi.org/10.1542/peds.2009-3239.